对比剂肾病学习资料课件.pptVIP

. * . * . By implementing sets of continuously monitored and refined quality measures in centers performing percuatenous coronary intervention (PCI), of which risk stratification, preprocedural hydration and reduction of used contrast dose (by avoiding unnecessary views) were key elements, considerable (often significant) improvements could be demonstrated over a historical and a contemporary control group in both surrogate endpoints (PCCI/CIN), but more importantly in hard clinical outcomes, such as nephropathy requiring dialysis, MI, stroke or TIA, or death. ACR Committee on Drugs and Cont